These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39028785)

  • 61. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
    Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
    Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recurrent syncope in a patient after myocardial infarction.
    Credner SC; Lehmann R; Grubb BP; Hohnloser SH; Klingenheben T
    Pacing Clin Electrophysiol; 2003 Apr; 26(4 Pt 1):920-1. PubMed ID: 12715857
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug treatment of orthostatic hypotension and vasovagal syncope.
    Frishman WH; Azer V; Sica D
    Heart Dis; 2003; 5(1):49-64. PubMed ID: 12549988
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope.
    Romme JJ; Reitsma JB; Black CN; Colman N; Scholten RJ; Wieling W; Van Dijk N
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD004194. PubMed ID: 21975744
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Not Available].
    Thorens A
    Rev Med Suisse; 2021 Nov; 17(758):1955. PubMed ID: 34755950
    [No Abstract]   [Full Text] [Related]  

  • 66. [Not Available].
    Gerber C
    Rev Med Suisse; 2022 Apr; 18(779):875. PubMed ID: 35481537
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide].
    Friederich HC; Michaelsen J; Hesse C; Schellberg D; Schwab M; Herzog W
    Z Kardiol; 2004 Jun; 93(6):479-85. PubMed ID: 15252742
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can prodromal symptoms predict recurrence of vasovagal syncope?
    Fazelifar AF; Basiri HA; Tolooie A; Haghjoo M; Barakpour H; Emkanjoo Z; Abkenar HB; Zeighami M; Asgari F; Sadr-Ameli MA
    Cardiol J; 2008; 15(5):446-50. PubMed ID: 18810720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
    Nakagawa H; Kobayashi Y; Kikushima S; Shinohara M; Obara C; Zinbo Y; Chiyoda K; Miyata A; Tanno K; Baba T; Katagiri T
    Jpn Circ J; 1998 Oct; 62(10):727-32. PubMed ID: 9805252
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Therapy of vasovagal syncope (nonpharmacologic therapy and pharmacotherapy)].
    Mitro P
    Vnitr Lek; 2000 Dec; 46(12):861-8. PubMed ID: 11214367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term outcome of patients with vasovagal syncope.
    Barón-Esquivias G; Errázquin F; Pedrote A; Cayuela A; Gómez S; Aguilera A; Campos A; Fernández M; Valle JI; Redondo M; Fernández JM; Martínez A; Burgos J; Martínez-Rubio A
    Am Heart J; 2004 May; 147(5):883-9. PubMed ID: 15131546
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.
    Sheldon R; Raj SR; Rose MS; Morillo CA; Krahn AD; Medina E; Talajic M; Kus T; Seifer CM; Lelonek M; Klingenheben T; Parkash R; Ritchie D; McRae M;
    J Am Coll Cardiol; 2016 Jul; 68(1):1-9. PubMed ID: 27364043
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2021; 110(16):998-999. PubMed ID: 34875862
    [No Abstract]   [Full Text] [Related]  

  • 74. A standardized education protocol significantly reduces traumatic injuries and syncope recurrence: an observational study in 316 patients with vasovagal syncope.
    Aydin MA; Mortensen K; Salukhe TV; Wilke I; Ortak M; Drewitz I; Hoffmann B; Müllerleile K; Sultan A; Servatius H; Steven D; von Kodolitsch Y; Meinertz T; Ventura R; Willems S
    Europace; 2012 Mar; 14(3):410-5. PubMed ID: 22048993
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management of refractory neurocardiogenic syncope.
    Ellenbogen KA; Wood MA; Kontos HA
    Ann Intern Med; 1998 Jan; 128(1):73. PubMed ID: 9424991
    [No Abstract]   [Full Text] [Related]  

  • 76. Usefulness of pindolol in neurocardiogenic syncope.
    Iskos D; Dutton J; Scheinman MM; Lurie KG
    Am J Cardiol; 1998 Nov; 82(9):1121-4, A9. PubMed ID: 9817494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beta-blockers no better than placebo in the treatment of vasovagal syncope.
    Phillips J; Krist A
    J Fam Pract; 2002 Nov; 51(11):921. PubMed ID: 12485542
    [No Abstract]   [Full Text] [Related]  

  • 78. Putting it together: a new treatment algorithm for vasovagal syncope and related disorders.
    Bloomfield DM; Sheldon R; Grubb BP; Calkins H; Sutton R
    Am J Cardiol; 1999 Oct; 84(8A):33Q-39Q. PubMed ID: 10568559
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test.
    Ventura R; Maas R; Zeidler D; Schoder V; Nienaber CA; Schuchert A; Meinertz T
    Pacing Clin Electrophysiol; 2002 May; 25(5):816-21. PubMed ID: 12049374
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical observation of irbesartan in treatment of vasovagal syncope.
    Han Y; Lü XY; Jiang WL; Yang YM; Chen TZ
    Chin Med Sci J; 2005 Mar; 20(1):15. PubMed ID: 15844305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.